DentalReach Evidence Review:
3D printable resins used in dental applications are usually marketed as biocompatible for use in dentistry. This is the reason for the increase in the use. Application should begin with diagnosis and prognosis, then weigh benefit, harm, alternatives, patient preference, feasibility and maintenance.
DentalReach Academic Editor:
Clinical transfer depends on matching the evidence to the patient, intervention, comparator, outcome, operator and care environment.
DentalReach Critical Appraisal:
Connected academic reading: Related DentalReach academic resource dentalreach.today/plus-is-the-new-minus-additive-manufacturing
Use this resource to compare diagnosis, risk assessment, treatment selection or maintenance rather than as an isolated recommendation.
Sign in to join this discussion.
Where are the clinical boundaries of Chemotherapy agents and dentistry?
DentalReach Evidence Review: Chemotherapy is a type of treatment given to cancer patients who are under…
31w ago
Which clinical conditions could change the conclusions of Bioactive Materials in Dentistry: A Groundbreaking Review?
DentalReach Critical Appraisal: Shared decision-making should cover benefit, uncertainty, alternatives,…
31w ago
Where are the clinical boundaries of Nano-Diamonds: A Ray Of Hope Against Antibiotic Resistance?
DentalReach Practice Perspective: The safety boundary should be explicit: which finding triggers additional…
41w ago
Where are the clinical boundaries of Post COVID Dentistry - Safety & Prevention?
DentalReach Evidence Review: Reopening a dental practice post COVID-19 is a welcome event. But while opening…
31w ago